UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm

International journal of molecular sciences, 2020-12, Vol.22 (1), p.75

2020

Volltextzugriff (PDF)

Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression

Frontiers in immunology, 2018-08, Vol.9, p.1977

2018

Volltextzugriff (PDF)

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

Frontiers in immunology, 2018-09, Vol.9, p.2052-2052

2018

Volltextzugriff (PDF)

Immunogenicity Risk Profile of Nanobodies

Frontiers in immunology, 2021-03, Vol.12, p.632687

2021

Volltextzugriff (PDF)

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

Cell reports (Cambridge), 2017-08, Vol.20 (8), p.1818-1829

2017

Volltextzugriff (PDF)

mRNA in cancer immunotherapy: beyond a source of antigen

Molecular cancer, 2021-03, Vol.20 (1), p.48-48, Article 48

2021

Volltextzugriff (PDF)

Combinatorial strategies for the induction of immunogenic cell death

Frontiers in immunology, 2015-04, Vol.6, p.187-187

2015

Volltextzugriff (PDF)

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy

Theranostics, 2018-01, Vol.8 (13), p.3559-3570

2018

Volltextzugriff (PDF)

Role of non-classical MHC class I molecules in cancer immunosuppression

Oncoimmunology, 2013-11, Vol.2 (11), p.e26491-e26491

2013

Volltextzugriff (PDF)

Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines

Journal of Immunology Research, 2015-01, Vol.2015, p.785634-18

2015

Volltextzugriff (PDF)

Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

Cancer research (Chicago, Ill.), 2018-03, Vol.78 (5), p.1155-1168

2018

Volltextzugriff (PDF)

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Journal of Nuclear Medicine, 2021-11, Vol.62 (11), p.1638-1644

2021

Volltextzugriff (PDF)

The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy

Journal of controlled release, 2014-11, Vol.194, p.28-36

2014

Volltextzugriff (PDF)

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (7), p.1661-1671

2012

Volltextzugriff (PDF)

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5634

2024

Volltextzugriff (PDF)

Neo-Antigen mRNA Vaccines

Vaccines (Basel), 2020-12, Vol.8 (4), p.776

2020

Volltextzugriff (PDF)

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

Cancers, 2019-06, Vol.11 (6), p.872

2019

Volltextzugriff (PDF)

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Scientific reports, 2023-11, Vol.13 (1), p.18995-18995, Article 18995

2023

Volltextzugriff (PDF)

Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1 + Myeloid Dendritic Cells

International journal of molecular sciences, 2022-04, Vol.23 (9), p.4865

2022

Volltextzugriff (PDF)

HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7

Journal of Virology, 2010-06, Vol.84 (11), p.5627-5636

2010

Volltextzugriff (PDF)

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry

Pharmaceuticals (Basel, Switzerland), 2021-06, Vol.14 (6), p.550

2021

Volltextzugriff (PDF)

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

Frontiers in immunology, 2021-03, Vol.12, p.652160-652160

2021

Volltextzugriff (PDF)

Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation

Biomolecules (Basel, Switzerland), 2020-09, Vol.10 (10), p.1388

2020

Volltextzugriff (PDF)

Preclinical Targeted α- and β - -Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

Cancers, 2020-04, Vol.12 (4), p.1017

2020

Volltextzugriff (PDF)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Frontiers in cell and developmental biology, 2019-07, Vol.7, p.149-149

2019

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Englisch
(164)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm

Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

Immunogenicity Risk Profile of Nanobodies

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

mRNA in cancer immunotherapy: beyond a source of antigen

Combinatorial strategies for the induction of immunogenic cell death

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy

Role of non-classical MHC class I molecules in cancer immunosuppression

Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines

Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

Neo-Antigen mRNA Vaccines

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1 + Myeloid Dendritic Cells

HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation

Preclinical Targeted α- and β - -Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Suchergebnisse filtern